Zhejun Jia

Zhejun Jia is a seasoned professional in analytical development, currently serving as Principal Scientist at Allogene Therapeutics since August 2020, focusing on CAR T potency and characterization assay development, along with validation, qualification, and protocol documentation. Prior to this role, Zhejun held positions as Senior Scientist and Scientist at Allogene Therapeutics, where contributions included developing test methods and supporting assay protocols. Experience also includes a tenure at Ab Studio Inc. as a Scientist, specializing in antibody discovery and engineering from August 2017 to August 2020, and a long-term role at Molecular Cloning Laboratories as Lead of the Sanger sequencing department, overseeing molecular biology and quality control systems from May 2008 to August 2017. Zhejun began the professional career as a Staff Research Associate at UCSF, working on siRNA gene regulation. Academic credentials include a Master’s degree in Quality Management and Business Administration from Shanxi University of Finance and Economics and a Bachelor’s degree in Microbiology from Tianjin University of Commerce.